New guidelines for the treatment of arterial hypertension: advances and challenges
DOI:
https://doi.org/10.5281/zenodo.14016956Keywords:
Essential Hypertension, Cardiology, AntihypertensiveAbstract
Hypertension remains one of the main risk factors for cardiovascular diseases, and its adequate control is essential to prevent complications. This study reviews the main changes in hypertension treatment guidelines, with an emphasis on the new recommendations published in 2024 by the American College of Cardiology (ACC) and the American Heart Association (AHA). The analysis highlights updates related to blood pressure targets, the adoption of combination therapies, and the use of emerging technologies, such as SGLT2 inhibitors and digital monitoring devices. These strategies aim to improve hypertension control, especially in high-risk patients. Although challenges related to treatment adherence and implementation in low-income countries persist, recent advances offer new possibilities for more effective and individualized management of hypertension. Personalizing treatment, taking into account the risk profile and available resources, is essential to optimize outcomes and reduce cardiovascular mortality.
References
BURNIER, M. Medication Adherence and Persistence as the Cornerstone of Effective Antihypertensive Therapy. Journal of Hypertension, v. 37, n. 9, p. 1739-1746, 2019.
KAVANAGH, P. M.; FLYNN, D.; ALEXANDER, A. Novel Therapeutics for the Management of Hypertension: Focus on SGLT2 Inhibitors. Current Hypertension Reports, v. 23, n. 2, p. 112-120, 2022.
MILLS, K. T.; STEFANESCU, A.; HE, J. The global epidemiology of hypertension. Nature Reviews Nephrology, v. 16, n. 4, p. 223-237, 2020.
ORGANIZAÇÃO MUNDIAL DA SAÚDE (OMS). Hypertension. [S.l.: s.n.], 2023. Disponível em: https://www.who.int/news-room/fact-sheets/detail/hypertension. Acesso em: 6 out. 2024.
WRITING COMMITTEE MEMBERS et al. 2017. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, v. 71, n. 6, p. 1269-1324, 2018.
WILLIAMS, B. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal, v. 39, n. 33, p. 3021-3104, 2018.
ACC/AHA. 2024 Hypertension Guidelines: Executive Summary. Hypertension, 2024. Disponível em: https://www.acc.org/latest-in-cardiology/guidelines/2024-hypertension-guidelines. Acesso em: 06 out. 2024.
BURNIER, M. Medication Adherence and Persistence as the Cornerstone of Effective Antihypertensive Therapy. Journal of Hypertension, v. 37, n. 9, p. 1739-1746, 2019.
KAVANAGH, P. M.; FLYNN, D.; ALEXANDER, A. Novel Therapeutics for the Management of Hypertension: Focus on SGLT2 Inhibitors. Current Hypertension Reports, v. 23, n. 2, p. 112-120, 2022.
MILLS, K. T.; STEFANESCU, A.; HE, J. The global epidemiology of hypertension. Nature Reviews Nephrology, v. 16, n. 4, p. 223-237, 2020.
WRITING COMMITTEE MEMBERS et al. 2024 ACC/AHA Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 2024.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Journal of Social Issues and Health Sciences (JSIHS)
This work is licensed under a Creative Commons Attribution 4.0 International License.
